Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Defining the Predictors and Outcomes of Persistent Tricuspid Regurgitation after Transcatheter Atrial Septal Defect Closure
EF 2017-18
Résumé
Secundum atrial septal defect (ASD) is one of the most common congenital heart defects often diagnosed during adulthood. Over time, left-to-right atrial shunting results in right ventricle (RV) dilation, tricuspid regurgitation (TR) and occasionally, pulmonary hypertension. Moderate-to-severe functional TR is associated with poor event-free survival outcomes and increased risk for adverse cardiovascular events. Hemodynamically significant ASDs can be treated with percutaneous ASD closure or surgical closure and concomitant tricuspid valve annuloplasty (TAP) to prevent further dilation of the valve. Currently, clinical guidelines do not address optimal management options for adults with ASD and moderate-to-severe functional TR at the time of closure. My study aims to define the clinical and 3-dimensional (3D) echocardiographic baseline predictors associated with persistent TR. I hypothesize that significant TR after transcatheter ASD closure is predicted by baseline chronic atrial arrhythmia, severe RV enlargement, and increased tricuspid valve annulus diameter. Furthermore, patients with persistent moderate-to-severe TR may be associated with a worse prognosis than patients with minimal TR. Once clinical and 3D imaging predictors are identified, ASD patients who are at risk for persistent moderate-to-severe TR can be offered surgical ASD closure with TAP opposed to the standard percutaneous approach. This will prevent patients from undergoing multiple unnecessary procedures and receive the best possible long-term outcome.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
386675
Name
Bach Yvonne
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Defining the Predictors and Outcomes of Persistent Tricuspid Regurgitation after Transcatheter Atrial Septal Defect Closure
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
3-Dimensional Echocardiography; Atrial Fibrillation; Atrial Septal Defect; Congenital Heart Defect; Interventional Cardiology; Long-Term Outcomes; Optimal Patient Management; Right Heart Failure; Stroke; Tricuspid Valve Insufficiency
Abstract
Secundum atrial septal defect (ASD) is one of the most common congenital heart defects often diagnosed during adulthood. Over time, left-to-right atrial shunting results in right ventricle (RV) dilation, tricuspid regurgitation (TR) and occasionally, pulmonary hypertension. Moderate-to-severe functional TR is associated with poor event-free survival outcomes and increased risk for adverse cardiovascular events. Hemodynamically significant ASDs can be treated with percutaneous ASD closure or surgical closure and concomitant tricuspid valve annuloplasty (TAP) to prevent further dilation of the valve. Currently, clinical guidelines do not address optimal management options for adults with ASD and moderate-to-severe functional TR at the time of closure. My study aims to define the clinical and 3-dimensional (3D) echocardiographic baseline predictors associated with persistent TR. I hypothesize that significant TR after transcatheter ASD closure is predicted by baseline chronic atrial arrhythmia, severe RV enlargement, and increased tricuspid valve annulus diameter. Furthermore, patients with persistent moderate-to-severe TR may be associated with a worse prognosis than patients with minimal TR. Once clinical and 3D imaging predictors are identified, ASD patients who are at risk for persistent moderate-to-severe TR can be offered surgical ASD closure with TAP opposed to the standard percutaneous approach. This will prevent patients from undergoing multiple unnecessary procedures and receive the best possible long-term outcome.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bach, Yvonne
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~